Morphin Hexal (Morphine Sulfate Ph. Eur.)

Morphine Sulfate, the active ingredient in Morphin Hexal, is an opioid analgesic presented as an injectable solution for epidural, intramuscular and intrathecal use. It treats severe acute pain, post‑operative pain and cancer‑related pain in adult patients.

GNH USA supplies Morphin Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphin Hexal is an opioid analgesic used in the management of severe pain conditions.

- Severe acute pain: provides rapid relief of intense pain episodes. - Post‑operative pain: helps control pain after surgical procedures. - Cancer‑related pain: offers sustained analgesia for malignancy‑associated discomfort.

Morphin Hexal may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel movements. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness. - Itching: mild pruritus, often at the injection site.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Adrenal insufficiency: impaired cortisol production. - Seizures: rare convulsive episodes. - Anaphylaxis: life‑threatening allergic reaction.

When prescribing or handling Morphin Hexal, several safety considerations are essential.

- Assess opioid tolerance: evaluate patient’s prior opioid exposure before initiating therapy. - Monitor respiratory function: observe breathing rate and oxygen saturation, especially after dose adjustments. - Avoid concurrent CNS depressants: limit use with benzodiazepines or barbiturates. - Adjust dose in renal/hepatic impairment: reduce dosage for patients with compromised organ function. - Use with caution in the elderly: start at lower doses and titrate slowly. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Morphin Hexal can interact with other medicines, affecting safety and efficacy.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - CNS depressants (e.g., benzodiazepines): additive respiratory depression. - Respiratory depressants (e.g., barbiturates): heightened risk of fatal respiratory failure.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase morphine plasma levels. - CYP2D6 inhibitors (e.g., fluoxetine): can alter metabolism and effect. - Diuretics: may enhance hypotensive effects when combined.